The Collagen Folding Machinery: Biosynthesis and Post-Translational Modifications of Collagens - Osteogenesis Imperfecta - page 61

[45] Tuderman L, Kuutti ER, Kivirikko KI. An afinity-column
procedure using poly(L-proline) for the puriication of prolyl
hydroxylase. Puriication of the enzyme from chick embryos.
Eur J Biochem 1975;52(1):9-16.
[46] Koivu J, Myllyla R, Helaakoski T, Pihlajaniemi T, Tasanen K,
Kivirikko KI. A single polypeptide acts both as the beta subunit
of prolyl 4-hydroxylase and as a protein disulide-isomerase.
J Biol Chem 1987;262(14):6447-9.
[47] Pihlajaniemi T, Helaakoski T, Tasanen K, et al. Molecular clon-
ing of the beta-subunit of human prolyl 4-hydroxylase. This
subunit and protein disulphide isomerase are products of the
same gene. Embo J 1987;6(3):643-9.
[48] Privalov PL. Stability of proteins. Proteins which do not
present a single cooperative system. Adv Protein Chem
1982;35:1-104.
[49] Holster T, Pakkanen O, Soininen R, et al. Loss of assembly of
the main basement membrane collagen, type IV, but not ibril-
forming collagens and embryonic death in collagen prolyl
4-hydroxylase I null mice. J Biol Chem 2007;282(4):2512-9.
[50] Tainmont J. History of osteogenesis imperfecta or brittle
bone disease: a few stops on a road 3000 years long. B-Ent
2007;3(3):157-73.
[51] Sillence DO, Rimoin DL. Classiication of osteogenesis imper-
fect. Lancet 1978;1(8072):1041-2.
[52] Warman ML, Cormier-Daire V, Hall C, et al. Nosology and
classiication of genetic skeletal disorders: 2010 revision. Am J
Med Genet A 2010;155A(5):943-68.
[53] Basel D, Steiner RD. Osteogenesis imperfecta: recent indings
shed new light on this once well-understood condition. Genet
Med 2009;11(6):375-85.
[54] Kefalides NA. Structure and biosynthesis of basement mem-
branes. Int Rev Connect Tissue Res 1973;6:63-104.
[55] Rhodes RK, Miller EJ. Physicochemical characterization
and molecular organization of the collagen A and B chains.
Biochemistry 1978;17(17):3442-8.
[56] Risteli J, Tryggvason K, Kivirikko KI. Prolyl 3-hydroxylase:
partial characterization of the enzyme from rat kidney cortex.
Eur J Biochem 1977;73(2):485-92.
[57] Tryggvason K, Risteli J, Kivirikko KI. Separation of prolyl
3-hydroxylase and 4-hydroxylase activities and the 4-hydroxy-
proline requirement for synthesis of 3-hydroxyproline. Biochem
Biophys Res Commun 1976;76(2):275-81.
[58] Tryggvason K, Majamaa K, Risteli J, Kivirikko KI. Partial purii-
cation and characterization of chick-embryo prolyl 3-hydroxylase.
Biochem J 1979;183(2):303-7.
[59] Ishikawa Y, Wirz J, Vranka JA, Nagata K, Bächinger HP.
Biochemical characterization of the prolyl 3-hydroxylase 1.car-
tilage-associated protein.cyclophilin B complex. J Biol Chem
2009;284(26):17641-47.
[60] Marini JC, Cabral WA, Barnes AM, Chang W. Components of
the collagen prolyl 3-hydroxylation complex are crucial for
normal bone development. Cell Cycle 2007;6(14):1675-81.
[61] Hudson DM, Kim LS, Weis M, Cohn DH, Eyre DR. Peptidyl
3-hydroxyproline binding properties of type I collagen sug-
gest a function in ibril supramolecular assembly. Biochemistry
2012;51(12):2417-24.
[62] Barnes AM, Chang W, Morello R, et al. Deiciency of cartilage-
associated protein in recessive lethal osteogenesis imperfecta.
N Engl J Med 2006;355(26):2757-64.
[63] Barnes AM, Carter EM, Cabral WA, et al. Lack of cyclophilin
B in osteogenesis imperfecta with normal collagen folding.
N Engl J Med 2010;362(6):521-8.
[64] Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC.
Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing
in the endoplasmic reticulum collagen prolyl 3-hydroxylation
complex. Hum Mol Genet 2010;19(2):223-34.

[65] Kozlov G, Bastos-Aristizabal S, Maattanen P, et al. Structural
basis of cyclophilin B binding by the calnexin / calreticulin
P-domain. J Biol Chem 2010;285(46):35551-57.
[66] Bächinger HP, Morris NP, Davis JM. Thermal stability and fold-
ing of the collagen triple helix and the effects of mutations in
osteogenesis imperfecta on the triple helix of type I collagen.
Am J Med Genet 1993;45(2):152-62.
[67] Steinmann B, Bruckner P, Superti-Furga A. Cyclosporin A
slows collagen triple-helix formation in vivo: indirect evidence
for a physiologic role of peptidyl-prolyl cis-trans-isomerase.
J Biol Chem 1991;266(2):1299-303.
[68] Jansen G, Maattanen P, Denisov AY, et al. An interaction
map of ER chaperones and foldases. Mol Cell Proteomics
2012;11(9):710-23.
[69] Meunier L, Usherwood YK, Chung KT, Hendershot LM. A sub-
set of chaperones and folding enzymes form multiprotein com-
plexes in endoplasmic reticulum to bind nascent proteins. Mol
Biol Cell 2002;13(12):4456-69.
[70] Zhang L, Wu G, Tate CG, Lookene A, Olivecrona G.
Calreticulin promotes folding / dimerization of human lipo-
protein lipase expressed in insect cells (sf21). J Biol Chem
2003;278(31):29344-51.
[71] Ishikawa Y, Vranka JA, Boudko SP, et al. The mutation in
cyclophilin B that causes hyperelastosis cutis in the American
Quarter Horse does not affect peptidyl-prolyl cis-trans isomerase
activity, but shows altered cyclophilin B-protein interactions and
affects collagen folding. J Biol Chem 2012;287(26):22253-65.
[72] Swanson SK, Born T, Zydowsky LD, et al. Cyclosporin-
mediated inhibition of bovine calcineurin by cyclophilins A
and B. Proc Natl Acad Sci USA 1992;89(9):3741-5.
[73] Bukrinsky MI. Cyclophilins: unexpected messengers in inter-
cellular communications. Trends Immunol 2002;23(7):323-5.
[74] Watashi K, Ishii N, Hijikata M, et al. Cyclophilin B is a func-
tional regulator of hepatitis C virus RNA polymerase. Mol Cell
2005;19(1):111-22.
[75] Rycyzyn MA, Reilly SC, O'Malley K, Clevenger CV. Role of
cyclophilin B in prolactin signal transduction and nuclear ret-
rotranslocation. Mol Endocrinol 2000;14(8):1175-86.
[76] Constantinou CD, Nielsen KB, Prockop DJ. A lethal variant of
osteogenesis imperfecta has a single base mutation that sub-
stitutes cysteine for glycine 904 of the alpha 1(I) chain of type
I procollagen. The asymptomatic mother has an unidentiied
mutation producing an overmodiied and unstable type I pro-
collagen. J Clin Invest 1989;83(2):574-84.
[77] Cohn DH, Byers PH, Steinmann B, Gelinas RE. Lethal osteo-
genesis imperfecta resulting from a single nucleotide change
in one human pro alpha 1(I) collagen allele. Proc Natl Acad Sci
USA 1986;83(16):6045-7.
[78] Steinmann B, Rao VH, Vogel A, Bruckner P, Gitzelmann
R, Byers PH. Cysteine in the triple-helical domain of one
allelic product of the alpha 1(I) gene of type I collagen pro-
duces a lethal form of osteogenesis imperfecta. J Biol Chem
1984;259(17):11129-38.
[79] van Dijk FS, Cobben JM, Pals G. Osteogenesis imperfecta, nor-
mal collagen folding, and lack of cyclophilin B. N Engl J Med
2010;362(20): 1 940-1. author reply 1941-2.
[80] Makareeva E, Aviles NA, Leikin S. Chaperoning osteogen-
esis: new protein-folding disease paradigms. Trends Cell Biol
2011;21(3):168-76.
[81] Raghunath M, Bruckner P, Steinmann B. Delayed triple helix
formation of mutant collagen from patients with osteogenesis
imperfecta. J Mol Biol 1994;236(3):940-9.
[82] Schumacher MA, Mizuno K, Bächinger HP. The crystal struc-
ture of a collagen-like polypeptide with 3(S)-hydroxyproline
residues in the Xaa position forms a standard 7 / 2 collagen tri-
ple helix. J Biol Chem 2006;281(37):27566-74.